Journal Article

Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study

Chandra, Ronil V., Gilligan, Christopher, Gasquet, Nicolas C., Brook, Allan, Wu, Charlotte, Ricker, Christine N., Hirsch, Joshua A.

2025

Overview

Summary The purpose of this study was to determine the real-world incidence and predictors of additional vertebroplasty or balloon kyphoplasty after initial vertebral augmentation, as a proxy for subsequent symptomatic vertebral fracture. Of patients, 15.5% underwent subsequent vertebral augmentation. The patient’s comorbidities are strongly associated with risk of subsequent treatment. Purpose To determine the real-world incidence and predictors of additional vertebroplasty or balloon kyphoplasty after initial vertebral augmentation, as a proxy for subsequent symptomatic and disabling vertebral fracture. Methods We conducted a retrospective cohort study using commercial insurance claims data (Optum’s de-identified Clinformatics® Data Mart Database). Adult patients who underwent subsequent treatment for vertebral fracture within 24 months of initial balloon kyphoplasty (BKP) or vertebroplasty (VP) were classified into “subsequent treatment” or “no subsequent treatment” cohorts. Survival analysis was applied to investigate the effect of risk factors on subsequent treatment. Results Between 1 January 2008 and 30 June 2020, a total of 32,513 adult patients underwent a BKP/VP procedure following a diagnosis of vertebral compression fracture in the preceding 12 months. Five thousand thirty-five patients (15.5%) underwent a subsequent BKP/VP treatment within 2 years; 90% had a single fracture level treated. An increased hazard of subsequent treatment was associated with a number of fractures treated at initial BKP/VP (≥ 4 levels, adjusted hazard ratio (AHR) 1.68 (95% CI 1.24–2.26); steroid use, AHR 1.9 (95% CI 1.31–1.48); Elixhauser Comorbidity Index ≥ 4, AHR 1.44 (95% CI 1.17–1.77); and multiple myeloma, AHR 1.31 (95% CI 1.13–1.53)). Age < 70 years was associated with reduced hazard of subsequent treatment (AHR 0.81, 95% CI 0.74–0.89). Conclusions One in seven patients underwent subsequent treatment for vertebral fracture after initial vertebral augmentation. Baseline patient characteristics were associated with increased risk of subsequent fracture within 2 years, suggesting that a patient’s natural history is strongly associated with risk of subsequent treatment rather than the initial surgical procedure itself.

• Publisher: Springer London,Springer Nature B.V
• Subject: Adult / Aged / Aged, 80 and over / Balloon treatment / Bone surgery / Cohort analysis / Comorbidity / Endocrinology / Female / Fractures / Fractures, Compression - epidemiology / Fractures, Compression - surgery / Health risks / Humans / Incidence / Kyphoplasty - adverse effects / Kyphoplasty - methods / Kyphoplasty - statistics & numerical data / Male / Medical treatment / Medicine / Medicine & Public Health / Middle Aged / Minimally invasive surgery / Multiple myeloma / Original / Original Article / Orthopedics / Osteoporotic Fractures - epidemiology / Osteoporotic Fractures - etiology / Osteoporotic Fractures - surgery / Patients / Reoperation - statistics & numerical data / Retrospective Studies / Rheumatology / Risk Factors / Spinal Fractures - epidemiology / Spinal Fractures - etiology / Spinal Fractures - surgery / Survival analysis / United States - epidemiology / Vertebrae / Vertebroplasty - adverse effects / Vertebroplasty - methods / Vertebroplasty - statistics & numerical data